首页> 外国专利> A clade 2.3.4.4B H5 A Recombinant Influenza A virus and Vaccine Composition for H5 Serotype Influenza A virus belonging to clade 2.3.4.4B comprising the same

A clade 2.3.4.4B H5 A Recombinant Influenza A virus and Vaccine Composition for H5 Serotype Influenza A virus belonging to clade 2.3.4.4B comprising the same

机译:进化枝2.3.4.4B H5 A型重组流感病毒和属于进化枝2.3.4.4B的H5血清型A型流感病毒的疫苗组合物

摘要

The present invention provides a vaccine composition for a recombinant influenza A virus, a method for manufacturing the same, and an H5 serotype influenza A virus belonging to clade 2.3.4.4B including the same. The present invention may contribute to disease control through a protective effect against a H5 serotype highly pathogenic avian influenza outbreak, which is introduced from overseas or occurs in Korea, by preparing a genetic recombinant vaccine showing a protective effect on a highly pathogenic avian influenza virus. In addition, the vaccine composition is excellent in pathogenicity and safety, as well as the high pathogenicity of the HA segment is removed, and is excellent in proliferation in eggs (egg) and defense in chickens.
机译:本发明提供了用于重组A型流感病毒的疫苗组合物,其制备方法以及属于进化枝2.3.4.4B的H5血清型A型流感病毒。通过制备对高致病性禽流感病毒具有保护作用的基因重组疫苗,本发明可通过对从国外引入或在韩国发生的H5血清型高致病性禽流感爆发的保护作用而有助于疾病控制。另外,该疫苗组合物具有优异的致病性和安全性,并且去除了HA区段的高致病性,并且具有优异的卵(蛋)增殖和鸡防御能力。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号